Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Market status
Market status
Under Development
Products 71 to 80 of 119
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Malonic Acid
by
Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
13,100,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Mascoma Cellulosic Ethanol (Yeast)
by
Lallemand
+
Mascoma
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
179,800,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Methane bioconversion: 1,4 BDO
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (6 years ago)
Date last modified:
2019/09/13 11:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: 2,3 BDO
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (6 years ago)
Date last modified:
2019/09/13 11:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
+
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: Isobutyraldehyde
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (6 years ago)
Date last modified:
2019/09/13 11:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Mosameat
by
Mosameat
Biotech components:
Animal
Business models:
B2B
+
B2C
Country of production:
Netherlands
Country of distribution:
Netherlands
Intended consumer:
Commercial
+
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:50 (7 years ago)
Known funding amount:
7,500,000 EUR
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Muconic Acid
by
GC Innovation America
+
Myriant
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/09/13 15:30 (7 years ago)
Known funding amount:
110,000,000 USD
Funding types:
Government
+
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Mycelium Based Biomaterials
by
MycoWorks
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fiber
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
Mycelium Materials
by
BIOHM
Biotech components:
Fungus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/11/19 09:36 (7 years ago)
Date last modified:
2018/11/19 09:36 (7 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Industrial
+
Multipurpose
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
N/A
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Myristoyl Glutamate (Surfactant)
by
Modular Genetics, Inc.
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
1,121,998 USD
Funding types:
Private Funding
+
University
+
Government
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
1
…
3
4
5
6
7
8
9
10
11
12
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
